Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 17, 2005Journal of Clinical OncologyOpen Access

Combination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients With Relapsed Testicular Germ Cell Tumors

View Full Paper
Ask AI
Bookmark
Share

Authors

GKG. Varuni KondaguntaFox Chase Cancer CenterJBJennifer BacikCleveland ClinicADAlessia DonadioSt. Francis Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kondagunta et al. (2005) studied this question.

synapsesocial.com/papers/6aa92c8fc2bf00bae84622d3https://doi.org/10.1200/jco.2005.19.638
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors.1986 · 202 citations
  2. 2Salvage chemotherapy for patients with germ cell tumors. The memorial sloan-kettering cancer center experience (1979–1989)1991 · 136 citations
  3. 3High Dose Chemotherapy and Stem Cell Support in the Treatment of Germ Cell Cancer2003 · 11 citations
  4. 4Salvage Treatment With Paclitaxel, Ifosfamide, and Cisplatin Plus High-Dose Carboplatin, Etoposide, and Thiotepa Followed by Autologous Stem-Cell Rescue in Patients With Relapsed or Refractory Germ Cell Cancer2001 · 140 citations
  5. 5Nonparametric Estimation from Incomplete Observations1958 · 39,539 citations